Next, CCK‐8 assay and transwell assay were performed, and the results showed that the downregulation of FAM83A significantly inhibited NSCLC cell viability (Figure 3c,d) and metastatic ability (Figure 3e,f). Here, SACK1A is linked to non-small cell lung carcinoma.